141 related articles for article (PubMed ID: 35940023)
1. Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes.
Ribeiro N; Bulut I; Pósa V; Sergi B; Sciortino G; Pessoa JC; Maia LB; Ugone V; Garribba E; Enyedy ÉA; Acilan C; Correia I
J Inorg Biochem; 2022 Oct; 235():111932. PubMed ID: 35940023
[TBL] [Abstract][Full Text] [Related]
2. Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes.
Ribeiro N; Bulut I; Sergi B; Pósa V; Spengler G; Sciortino G; André V; Ferreira LP; Biver T; Ugone V; Garribba E; Costa-Pessoa J; Enyedy ÉA; Acilan C; Correia I
Front Chem; 2023; 11():1106349. PubMed ID: 37025548
[TBL] [Abstract][Full Text] [Related]
3. Cu(II) and Zn(II) Complexes of New 8-Hydroxyquinoline Schiff Bases: Investigating Their Structure, Solution Speciation, and Anticancer Potential.
Côrte-Real L; Pósa V; Martins M; Colucas R; May NV; Fontrodona X; Romero I; Mendes F; Pinto Reis C; Gaspar MM; Pessoa JC; Enyedy ÉA; Correia I
Inorg Chem; 2023 Jul; 62(29):11466-11486. PubMed ID: 37441730
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic oxidovanadium(IV) complexes of tridentate halogen-substituted Schiff bases: First dinuclear V(IV) complexes with O → V
Rudbari HA; Saadati A; Aryaeifar M; Correia I; Marques F; Blacque O; Micale N
Bioorg Med Chem Lett; 2021 Oct; 49():128285. PubMed ID: 34303813
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship on DNA binding and anticancer activities of a family of mixed-ligand oxidovanadium(V) hydrazone complexes.
Patra D; Paul S; Sepay N; Kundu R; Ghosh T
J Biomol Struct Dyn; 2018 Dec; 36(16):4143-4155. PubMed ID: 29171343
[TBL] [Abstract][Full Text] [Related]
6. Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction.
Banerjee A; Dash SP; Mohanty M; Sanna D; Sciortino G; Ugone V; Garribba E; Reuter H; Kaminsky W; Dinda R
J Inorg Biochem; 2019 Oct; 199():110786. PubMed ID: 31377474
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiproliferative effect of vanadium complexes bearing 8-hydroxyquinoline-based ligands - the substituent effect.
Choroba K; Raposo LR; Palion-Gazda J; Malicka E; Erfurt K; Machura B; Fernandes AR
Dalton Trans; 2020 May; 49(20):6596-6606. PubMed ID: 32342090
[TBL] [Abstract][Full Text] [Related]
8. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.
Benítez J; Cavalcanti de Queiroz A; Correia I; Alves MA; Alexandre-Moreira MS; Barreiro EJ; Lima LM; Varela J; González M; Cerecetto H; Moreno V; Pessoa JC; Gambino D
Eur J Med Chem; 2013 Apr; 62():20-7. PubMed ID: 23353731
[TBL] [Abstract][Full Text] [Related]
9. Copper(II) and oxidovanadium(IV) complexes of chromone Schiff bases as potential anticancer agents.
Nunes P; Yildizhan Y; Adiguzel Z; Marques F; Costa Pessoa J; Acilan C; Correia I
J Biol Inorg Chem; 2022 Feb; 27(1):89-109. PubMed ID: 34817681
[TBL] [Abstract][Full Text] [Related]
10. Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.
Maurya MR; Khan AA; Azam A; Ranjan S; Mondal N; Kumar A; Avecilla F; Pessoa JC
Dalton Trans; 2010 Feb; 39(5):1345-60. PubMed ID: 20104362
[TBL] [Abstract][Full Text] [Related]
11. Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity.
Bhattacharyya U; Kumar B; Garai A; Bhattacharyya A; Kumar A; Banerjee S; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Oct; 56(20):12457-12468. PubMed ID: 28972748
[TBL] [Abstract][Full Text] [Related]
12. Vanadium complexes having [VO]2+, [VO]3+ and [VO2]+ cores with hydrazones of 2,6-diformyl-4-methylphenol: synthesis, characterization, reactivity, and catalytic potential.
Maurya MR; Haldar C; Kumar A; Kuznetsov ML; Avecilla F; Costa Pessoa J
Dalton Trans; 2013 Sep; 42(33):11941-62. PubMed ID: 23680862
[TBL] [Abstract][Full Text] [Related]
13. Exploring the effect of substituent in the hydrazone ligand of a family of μ-oxidodivanadium(v) hydrazone complexes on structure, DNA binding and anticancer activity.
Patra D; Paul S; Majumder I; Sepay N; Bera S; Kundu R; Drew MGB; Ghosh T
Dalton Trans; 2017 Nov; 46(46):16276-16293. PubMed ID: 29138774
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of oxidovanadium(IV) by organic radicals.
Kundu S; Maity S; Maity AN; Ke SC; Ghosh P
Dalton Trans; 2013 Apr; 42(13):4586-601. PubMed ID: 23353872
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of V(IV)O complexes of picolinate and pyrazine derivatives. Behavior in the solid state and aqueous solution and biotransformation in the presence of blood plasma proteins.
Koleša-Dobravc T; Lodyga-Chruscinska E; Symonowicz M; Sanna D; Meden A; Perdih F; Garribba E
Inorg Chem; 2014 Aug; 53(15):7960-76. PubMed ID: 25013935
[TBL] [Abstract][Full Text] [Related]
16. New copper(II) and oxidovanadium(IV) complexes with a vitamin B
Balsa LM; Ferretti V; Sottile M; Nunes P; Costa Pessoa J; Correia I; León IE
Dalton Trans; 2024 Feb; 53(7):3039-3051. PubMed ID: 38111362
[TBL] [Abstract][Full Text] [Related]
17. Vanadium Chloro-Substituted Schiff Base Catecholate Complexes are Reducible, Lipophilic, Water Stable, and Have Anticancer Activities.
Murakami HA; Uslan C; Haase AA; Koehn JT; Vieira AP; Gaebler DJ; Hagan J; Beuning CN; Proschogo N; Levina A; Lay PA; Crans DC
Inorg Chem; 2022 Dec; 61(51):20757-20773. PubMed ID: 36519680
[TBL] [Abstract][Full Text] [Related]
18. Characterization and biotransformation in the plasma and red blood cells of V(IV)O(2+) complexes formed by ceftriaxone.
Sanna D; Fabbri D; Serra M; Buglyó P; Bíró L; Ugone V; Micera G; Garribba E
J Inorg Biochem; 2015 Jun; 147():71-84. PubMed ID: 25601642
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
[TBL] [Abstract][Full Text] [Related]
20. Heteroleptic Oxidovanadium(V) Complexes with Activity against Infective and Non-Infective Stages of
Scalese G; Machado I; Salinas G; Pérez-Díaz L; Gambino D
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
